Article Text

Download PDFPDF

HOMESIDE: home-based family caregiver-delivered music and reading interventions for people living with dementia: protocol of a randomised controlled trial
  1. Felicity Anne Baker1,
  2. Jodie Bloska2,
  3. Sabine Braat3,
  4. Anna Bukowska4,
  5. Imogen Clark1,5,
  6. Ming H Hsu2,
  7. Tone Kvamme6,
  8. Nicola Lautenschlager7,8,
  9. Young-Eun Claire Lee1,5,
  10. Agnieszka Smrokowska-Reichmann4,
  11. Tanara Vieira Sousa3,
  12. Karette A Stensaeth6,
  13. Jeanette Tamplin1,5,
  14. Thomas Wosch9,
  15. Helen Odell-Miller2
  1. 1Faculty of Fine Arts and Music, The University of Melbourne, Melbourne, Victoria, Australia
  2. 2Cambridge Institute for Music Therapy Research, Anglia Ruskin University, Cambridge, UK
  3. 3School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia
  4. 4Department of Occupational Therapy, University of Physical Education, Kraków, Poland
  5. 5Austin Health, Melbourne, Victoria, Australia
  6. 6Centre for Research in Music and Health, Norwegian Academy of Music, Oslo, Norway
  7. 7Department of Psychiatry, The University of Melbourne, Melbourne, Victoria, Australia
  8. 8NorthWestern Mental Health, Melbourne Health, Melbourne, Victoria, Australia
  9. 9Hochschule für angewandte Wissenschaften Würzburg-Schweinfurt, Würzburg, Germany
  1. Correspondence to Dr Felicity Anne Baker; felicity.baker{at}


Introduction Pharmacological interventions to address behavioural and psychological symptoms of dementia (BPSD) can have undesirable side effects, therefore non-pharmacological approaches to managing symptoms may be preferable. Past studies show that music therapy can reduce BPSD, and other studies have explored how formal caregivers use music in their caring roles. However, no randomised study has examined the effects on BPSD of music interventions delivered by informal caregivers (CGs) in the home setting. Our project aims to address the need for improved informal care by training cohabiting family CGs to implement music interventions that target BPSD, and the quality of life (QoL) and well-being of people with dementia (PwD) and CGs.

Methods and analysis A large international three-arm parallel-group randomised controlled trial will recruit a sample of 495 dyads from Australia, Germany, UK, Poland and Norway. Dyads will be randomised equally to standard care (SC), a home-based music programme plus SC, or a home-based reading programme plus SC for 12 weeks. The primary outcome is BPSD of PwD (measured using the Neuropsychiatric Inventory-Questionnaire). Secondary outcomes will examine relationship quality between CG and PwD, depression, resilience, competence, QoL for CG and QoL for PwD. Outcomes will be collected at baseline, at the end of the 12-week intervention and at 6 months post randomisation. Resource Utilisation in Dementia will be used to collect economic data across the life of the intervention and at 6-month follow-up. We hypothesise that the music programme plus SC will generate better results than SC alone (primary comparison) and the reading programme plus SC (secondary comparison).

Ethics and dissemination Ethical approval has been obtained for all countries. Results will be presented at national and international conferences and published in scientific journals and disseminated to consumer and caregiver representatives and the community.

Trial registration numbers ACTRN12618001799246p; NCT03907748

  • music therapy
  • dementia
  • caregivers
  • home-based interventions
  • randomised controlled trial
  • behavioural and psychological symptoms of dementia

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors FAB took the initiative for the study; FAB, HO-M, TW, KAS, AB, JB developed the concept and design; SB developed the statistical analysis plan and TVS designed the health economics plan. IC, MHH, TK, NL, Y-ECL, AS-R, JT helped to revise the concept and design. FAB drafted the manuscript; all authors revised the manuscript for important intellectual content. All authors approved the final version of the manuscript.

  • Funding This work was supported by the Joint Programs for Neurodegenerative Diseases (JPND), which includes joint funding from the National Health and Medical Research Council (APP1169867), Norwegian Research Council (Project number 298995), Federal Ministry of Education and Research Germany (01ED1901) and The National Centre for Research and Development, Poland JPND/04/2019—The National Centre for Research and Development and Alzheimer’s Society, UK (grant no. 462).

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Ethics approval Australia Human Ethics Sub-Committee approval no. 1852845, the United Kingdom approval no. 19/EE/0177, Poland approval no. 186/KBL/OIL/2019, German approval no. DGP 19-013 and Norwegian Centre for Research Data (Ref 502736) and Norwegian REK Medical and Research Ethics (Ref 2019/941).

  • Provenance and peer review Not commissioned; externally peer reviewed.